Please make use of analysis of NervGen Pharma Corp fundamentals to determine if markets are correctly pricing the entity. We were able to analyze and collect data for twenty-six available fundamentals for NervGen Pharma, which can be compared to its peers in the industry. The stock experiences an unexpected upward trend. Watch out for market signals. Check odds of NervGen Pharma to be traded at C$3.71 in 90 days. Key indicators impacting NervGen Pharma's financial strength include:
Please note, the imprecision that can be found in NervGen Pharma's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of NervGen Pharma Corp. Check NervGen Pharma's Beneish M Score to see the likelihood of NervGen Pharma's management manipulating its earnings.
NervGen Pharma Stock Summary
NervGen Pharma competes with NervGen Pharma, Medicenna Therapeutics, and Arch Biopartners. NervGen Pharma Corp., a regenerative medicine company, engages in the discovery, development, and commercialization of therapeutics for the treatment of nerve damage, including spinal cord injuries and peripheral nerve injuries. The company was incorporated in 2017 and is based in Vancouver, Canada. NERVGEN PHARMA operates under Biotechnology classification in Canada and is traded on TSX Venture Exchange.
Foreign Associate
USA
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
You should never invest in NervGen Pharma without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of NervGen Stock, because this is throwing your money away. Analyzing the key information contained in NervGen Pharma's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
NervGen Pharma Key Financial Ratios
There are many critical financial ratios that NervGen Pharma's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that NervGen Pharma Corp reports annually and quarterly.
Comparative valuation techniques use various fundamental indicators to help in determining NervGen Pharma's current stock value. Our valuation model uses many indicators to compare NervGen Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across NervGen Pharma competition to find correlations between indicators driving NervGen Pharma's intrinsic value. More Info.
NervGen Pharma Corp is regarded second in return on equity category among its peers. It also is regarded second in return on asset category among its peers . At this time, NervGen Pharma's Return On Equity is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the NervGen Pharma's earnings, one of the primary drivers of an investment's value.
NervGen Pharma Corp Systematic Risk
NervGen Pharma's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. NervGen Pharma volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on NervGen Pharma Corp correlated with the market. If Beta is less than 0 NervGen Pharma generally moves in the opposite direction as compared to the market. If NervGen Pharma Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one NervGen Pharma Corp is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of NervGen Pharma is generally in the same direction as the market. If Beta > 1 NervGen Pharma moves generally in the same direction as, but more than the movement of the benchmark.
NervGen Pharma Corp Total Assets Over Time
Today, most investors in NervGen Pharma Stock are looking for potential investment opportunities by analyzing not only static indicators but also various NervGen Pharma's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of NervGen Pharma growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of NervGen Pharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of NervGen Pharma Corp. We use our internally-developed statistical techniques to arrive at the intrinsic value of NervGen Pharma Corp based on widely used predictive technical indicators. In general, we focus on analyzing NervGen Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build NervGen Pharma's daily price indicators and compare them against related drivers.
When running NervGen Pharma's price analysis, check to measure NervGen Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NervGen Pharma is operating at the current time. Most of NervGen Pharma's value examination focuses on studying past and present price action to predict the probability of NervGen Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NervGen Pharma's price. Additionally, you may evaluate how the addition of NervGen Pharma to your portfolios can decrease your overall portfolio volatility.